Paper 59 - PERK MEDIATED ENDOPLASMIC RETICULUM (ER) STRESS ACTIVATION IS A KEY MODULATOR OF TMZ-INDUCED ACTIVATION OF THE DR-5 IN SUCCINATE DEHYDROGENASE (SDH)-DEFICIENT GASTROINTESTINAL STROMAL TUMOR (GIST)

Author(s)

• SM

  Shashwath Kalladi Malli, PhD (he/him/his)

  POST DOCTORAL FELLOW
  University of California San Diego
  San Diego, California, United States

  Slides

Co-Author(s)

• 

  Manikandan Murugesan, PhD (he/him/his)

  POST DOCTORAL FELLOW
  University of California San Diego
  San Diego, California, United States
• KL

  Kentson Lam, M.D., Ph.D.

  ASSISTANT PROFESSOR OF CLINICAL MEDICINE
  University of California San Diego
  San Diego, California, United States
• AS

  Ashwyn Sharma, MD

  University of California, San Diego
  La Jolla, California, United States
• 

  Mark Antkowiak, MD

  Post Doctoral Fellow
  University of California, San Diego
  La Jolla, California, United States
• DG

  Diwakar Guragain, Ph.D.

  Post Doctoral Fellow
  University of California San Diego
  San Diego, California, United States
• CT

  Chih-Min Tang, Ph.D.

  Staff Research Associate-3
  University of California San Diego
  San Diego, California, United States
• SB

  Shruti Bharghava, Ph.D.

  Post Doctoral Fellow
  University of California San Diego
  San Diego, California, United States
• SP

  Selena Palazuelos, Undergraduate

  Undergraduate
  University of California San Diego
  San Diego, California, United States
• AS

  Adrian Sanchez-Fdez, Ph.D.

  Post Doctoral Fellow
  University of California San Diego
  San Diego, California, United States
• TD

  Terence M. Doherty, n/a

  Senior Science Writer
  University of California San Diego
  San Diego, California, United States
• PF

  Paul Fanta, M.D.

  Professor
  University of California, San Diego
  La Jolla, California, United States
• AB

  Adam M. Burgoyne, M.D., Ph.D.

  Assistant Clinical Professor
  University of California San Diego
  San Diego, California, United States
• RS

  Robert A.J. Signer, Ph.D.

  Associate Professor
  University of California San Diego
  San Diego, California, United States
• KW

  Katelyn Willis, n/a

  Collaborator
  Inhibrx Biosciences Inc.
  San Diego, California, United States
• VA

  Vasily Andrianov, M.D.

  VP-Clinical Development
  Inhibrx Biosciences Inc.
  San Diego, California, United States
• JM

  Jill P. Mesirov, PhD

  Distinguished Professor
  Department of Medicine, University of California, San Diego
  San Diego, California, United States
• BE

  Brendan Eckelman, n/a

  Chief Scientific Officer
  Inhibrx Biosciences Inc.
  San Diego, California, United States
• JS

  Jason K. Sicklick, M.D., FACS

  Professor/Principal Investigator
  University of California, San Diego
  La Jolla, California, United States